Patents Assigned to MaveriX Oncology, Inc.
  • Small molecule drug conjugates of gemcitabine monophosphate
    Patent number: 11760773
    Abstract: Disclosed are compounds having formula (1): or a pharmaceutically acceptable salt, ester, amide, solvate, or stereoisomer thereof, wherein L, Y1, Y2, Y3, Y4, Y5, Z1, Z2, Z3, Z4, Z5, Z6 are each as defined in the specification; compositions thereof; uses thereof; and methods of use thereof.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: September 19, 2023
    Assignee: MaveriX Oncology, Inc.
    Inventors: Steven Albert Everett, Craig Alan Coburn